GC Cell stands at the forefront of cell therapy innovation with fully-integrated capability from research to commercialization. Offering customized solutions tailored to partners` needs, We provide end-to-end full value chain CDMO and bio logistics service. Our mission is to fast-track the innovation in cell and gene therapies, aiming to enhance the clinical outcomes of each and every patient, shaping the future of healthcare.
| Website | https://www.gccell.com |
| Revenue | $137.8 million |
| Employees | 147 (67 on RocketReach) |
| Address | 107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, Republic of Korea, Yongin-si, Gyeonggi-do 16924, KR |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Cdmo, Biologics, Research, Commercialization, Biomanufacturing, Cell Therapy Manufacturing, Process Development, Drug Development, Clinical Manufacturing, Bioprocessing, Pharmaceutical Manufacturing, Custom Manufacturing, Contract Manufacturing, Biopharmaceutical Manufacturing, Gene Therapy, Regenerative Medicine, Advanced Therapy Medicinal Products |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, AstraZeneca, GSK, CureVac, Novavax, Moderna Therapeutics, Merck AH +39 more (view full list) |
Looking for a particular GC Cell employee's phone or email?
The GC Cell annual revenue was $137.8 million in 2026.
Sungyong Won is the CEO and CSO of GC Cell.
67 people are employed at GC Cell.
GC Cell is based in Yongin-si, Gyeonggi-do.